Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- AVDL
- Price
- 21.64
- Stock movement up
- +0.01 (0.05%)
- Company name
- Avadel Pharmaceuticals PLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 2.12B
- Ent value
- 2.15B
- Price/Sales
- 8.55
- Price/Book
- 21.62
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 28.82
- PEG
- -
- EPS growth
- -10.39%
- 1 year return (CAGR)
- 138.06%
- 3 year return (CAGR)
- 42.62%
- 5 year return (CAGR)
- 21.81%
- 10 year return (CAGR)
- 8.57%
Last updated: 2026-02-20
DIVIDENDS
AVDL does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 59.67 |
| Price to FCF | 59.99 |
| Price to EBITDA | 209.67 |
| EV to EBITDA | 211.79 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 8.55 |
| Price to Book | 21.62 |
| EV to Sales | 8.63 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 98.15M |
| EPS (TTM) | -0.00 |
| FCF per share (TTM) | 0.35 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 248.52M |
| Gross profit (TTM) | 234.76M |
| Operating income (TTM) | 4.52M |
| Net income (TTM) | -278.00K |
| EPS (TTM) | -0.00 |
| EPS (1y forward) | 0.75 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 94.47% |
| Operating margin (TTM) | 1.82% |
| Profit margin (TTM) | -0.11% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 79.81M |
| Net receivables | 42.44M |
| Total current assets | 172.23M |
| Goodwill | 16.84M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 10.16M |
| Total assets | 199.45M |
| Accounts payable | 12.58M |
| Short/Current long term debt | 37.38M |
| Total current liabilities | 62.49M |
| Total liabilities | 101.22M |
| Shareholder's equity | 98.22M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 35.60M |
| Capital expenditures (TTM) | 191.76K |
| Free cash flow (TTM) | 35.41M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -0.28% |
| Return on Assets | -0.14% |
| Return on Invested Capital | -0.28% |
| Cash Return on Invested Capital | 35.78% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 21.66 |
| Daily high | 21.76 |
| Daily low | 21.63 |
| Daily Volume | 35.0M |
| All-time high | 42.85 |
| 1y analyst estimate | 20.94 |
| Beta | 1.63 |
| EPS (TTM) | -0.00 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 9 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AVDL | S&P500 | |
| Current price drop from All-time high | -49.50% | -0.51% |
| Highest price drop | -97.50% | -56.47% |
| Date of highest drop | 26 May 2022 | 9 Mar 2009 |
| Avg drop from high | -70.98% | -10.84% |
| Avg time to new high | 210 days | 12 days |
| Max time to new high | 5635 days | 1805 days |
COMPANY DETAILS
Marketcap
2.12B
Marketcap category
Mid-cap
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.
Employees
188
Website
Investor relations
-
SEC filings
CEO
Gregory J. Divis
Country
USA
City
Dublin
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner